Response to Motion to Intervene NOVO NORDISK v Cochran March 22, 2021

IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEW JERSEY

NOVO NORDISK INC.
and
NOVO NORDISK PHARMA, INC.,                                 Civil Action No. 3:21-cv-00806
                                                                                        Chief Judge Freda L. Wolfson
                             Plaintiffs,

UNITED STATES DEPARTMENT OF                            PLAINTIFFS’ RESPONSE TO
HEALTH AND HUMAN SERVICES,                               MOTION TO INTERVENE BY
et al.,                                                                               AMERICAN HOSPITAL
                                                                                        ASSOCIATION, ET AL.
                            Defendants.

Plaintiffs Novo Nordisk Inc. and Novo Nordisk Pharma, Inc. (together, “Novo”) take no position on the motion to intervene filed on March 2, 2021, by the American Hospital Association, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, Children’s Hospital Association, and American Society of Health-System Pharmacists. See ECF No. 20.

If the Court allows the movant-intervenors to participate in this case, however, Novo requests that the Court ensure that their participation does not interfere with the expeditious and efficient resolution of the issues raised in Novo’s complaint.